ReviewCancers2026

Checkpoint Blockade and Acquired Humoral Immune Dysregulation: Emerging Evidence for Antibody Deficiency During Long-Term PD-1/PD-L1 Inhibition.

Velizar ShivarovPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.